SINONASAL UNDIFFERENTIATED CARCINOMA
Clinical trials for SINONASAL UNDIFFERENTIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL UNDIFFERENTIATED CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy plus chemo shows promise for rare sinus cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before surgery can shrink advanced sinonasal tumors and reduce side effects. About 28 adults with a rare, aggressive sinus cancer will receive the combination, then surgery, followed by …
Matched conditions: SINONASAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE2 • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New combo therapy targets aggressive tumors with promising drug and radiation
Disease control Recruiting nowThis study tests whether adding the drug tarlatamab to standard radiation is safe and effective for cancers that have a protein called DLL3. About 30 adults with cancers like melanoma, lung cancer, or glioblastoma will receive the combination. The goal is to find the best timing …
Matched conditions: SINONASAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 26, 2026 12:06 UTC